[HTML][HTML] The roles of histone deacetylases and their inhibitors in cancer therapy
G Li, Y Tian, WG Zhu - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Genetic mutations and abnormal gene regulation are key mechanisms underlying
tumorigenesis. Nucleosomes, which consist of DNA wrapped around histone cores …
tumorigenesis. Nucleosomes, which consist of DNA wrapped around histone cores …
[HTML][HTML] Histone deacetylase inhibitors as anticancer drugs
T Eckschlager, J Plch, M Stiborova… - International journal of …, 2017 - mdpi.com
Carcinogenesis cannot be explained only by genetic alterations, but also involves
epigenetic processes. Modification of histones by acetylation plays a key role in epigenetic …
epigenetic processes. Modification of histones by acetylation plays a key role in epigenetic …
[HTML][HTML] Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors
Macrophages undergoing M1-versus M2-type polarization differ significantly in their cell
metabolism and cellular functions. Here, global quantitative time-course proteomics and …
metabolism and cellular functions. Here, global quantitative time-course proteomics and …
The role of enhancers in cancer
Enhancer elements function as the logic gates of the genetic regulatory circuitry. One of their
most important functions is the integration of extracellular signals with intracellular cell fate …
most important functions is the integration of extracellular signals with intracellular cell fate …
[HTML][HTML] HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases
Histone deacetylases (HDACs) are enzymes that play a key role in the epigenetic regulation
of gene expression by remodeling chromatin. Inhibition of HDACs is a prospective …
of gene expression by remodeling chromatin. Inhibition of HDACs is a prospective …
Epigenetics in cancer
M Esteller - New England Journal of Medicine, 2008 - Mass Medical Soc
Gene transcription can be activated or inhibited by a reversible modification of the gene; this
modification is termed an epigenetic change. This account of epigenetics in cancer reviews …
modification is termed an epigenetic change. This account of epigenetics in cancer reviews …
[HTML][HTML] Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs
HJ Kim, SC Bae - American journal of translational research, 2011 - ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that
play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis …
play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis …
[HTML][HTML] Targeting histone deacetylases with natural and synthetic agents: an emerging anticancer strategy
Cancer initiation and progression are the result of genetic and/or epigenetic alterations.
Acetylation-mediated histone/non-histone protein modification plays an important role in the …
Acetylation-mediated histone/non-histone protein modification plays an important role in the …
Histone deacetylases (HDACs): characterization of the classical HDAC family
Transcriptional regulation in eukaryotes occurs within a chromatin setting, and is strongly
influenced by the post-translational modification of histones, the building blocks of …
influenced by the post-translational modification of histones, the building blocks of …
Anticancer activities of histone deacetylase inhibitors
JE Bolden, MJ Peart, RW Johnstone - Nature reviews Drug discovery, 2006 - nature.com
Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …